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ABSTRACT 
Population bottlenecks often cause strong reductions in genetic diversity and alter population 
structure. In the context of host-parasite interactions, bottlenecks could in theory benefit 
either the host or the pathogen. We predicted that bottlenecking of bacterial populations that 
evolve CRISPR immunity against bacteriophages (phage) would benefit the pathogen, 
because CRISPR spacer diversity can rapidly drive phages extinct. To test this, we 
bottlenecked populations of bacteria and phage, tracking phage persistence and the evolution 
of bacterial resistance mechanisms. Contrary to our prediction, bottlenecking worked in the 
advantage of the host. With some possible exceptions, this effect was not caused by CRISPR 
immunity. This host benefit is consistent with a dilution effect disproportionately affecting 
phage. This study provides further insight into how bottlenecking influences bacteria-phage 
dynamics, the role of dilution in bacteria-phage interactions, and the evolution of host 
immune systems.  
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Introduction 
Many bacteria encode CRISPR-Cas immune systems [Clustered Regularly Interspaced Short 
Palindromic Repeats, CRISPR-associated], a RNA-guided mechanism used to defend against 
phage infection [1]. In response to phage infection, CRISPR-Cas immune systems can 
incorporate short DNA fragments of about 30 base pairs derived from the phage genome into 
CRISPR loci on the host genome, termed spacers [2, 3]. CRISPR transcripts are processed 
into small RNAs (crRNA) that bind to CRISPR-associated (Cas) proteins, which guide the 
recognition and cleavage of complementary nucleic acid sequences. In the case of reinfection 
by the same phage genotype (or a related phage genotype carrying the cognate sequence), 
CRISPR-Cas systems can target and cleave the invading phage genome, preventing 
successful re-infections [4-6]. CRISPR loci in bacterial populations are often diverse [7-9]. 
High levels of CRISPR spacer diversity naturally evolve in bacterial populations with type I-
F CRISPR-Cas systems due to primed spacer acquisition [10]. Priming relies on a partial 
match between a pre-existing spacer and the phage genome [9, 11], and causes an increase in 
the rate of spacer acquisition. Increasing CRISPR diversity can contribute to synergistic host 
benefits and cause increasingly rapid phage extinction [12-14]. 
The levels of genetic diversity in populations of hosts and parasites are known to play a key 
role in determining the spread and evolution of infectious diseases. For example, host genetic 
diversity can limit the spread of pathogens (reviewed in [15, 16]) whereas parasite genetic 
diversity can increase the ability of parasites to adapt to local hosts [17]. Population 
bottlenecks - characterised by sudden, often repeated and usually drastic reductions in 
population size - are common in host-pathogen populations and can strongly reduce their 
genetic diversity [18, 19]. Bottlenecks in host-pathogen systems can be levied by clinical 
treatment, such as antibiotics [20]; as part of the normal infection cycle of a pathogen 
(e.g. Lyme Disease [21], HIV-1 [22], Hepatitis C virus [23], reviewed in [24]; or sudden 
changes in the abiotic environment, such as soil structure [25].  
Bottlenecks can influence host-pathogen interactions in several ways. Bottlenecking can 
benefit the pathogen, as the reduction in host diversity increases the ability of pathogens to 
adapt to overcome host defenses [17, 26, 27]. Conversely, bottlenecks can limit the spread of 
parasites by a dilution effect [28, 29], where low host density reduces contact rate between 
susceptible individuals (e.g. [30-32]), or by stochastic fixation of resistance alleles [33, 34]. 
The only experimental test of bottlenecking in a bacteria-bacteriophage (phage) system 
supported a host benefit, which the authors suggest was due to highly-frequent resistant host 
phenotypes being more likely to pass through successive bottlenecks and fix in the population 
[35]. Dennehy et al. [30] also found that wildtype Pseudomonas phaselicola, which are 
susceptible to phage, benefited from a dilution effect when in mixed cultures with a pilus 
mutant strain that prevents phage attachment. However, bottlenecking would be expected to 
generally work in the advantage of the parasite when hosts rely on a diversity-generating 
immune mechanism [36] such as CRISPR.  
Here we set out to explore the consequences of bottlenecking in the context of CRISPR using 
P. aeruginosa strain PA14, which has a type I-F CRISPR-Cas system and readily evolves 
CRISPR immunity against its phage DMS3vir [9, 10]. Given that the benefits of CRISPR 
immunity can depend on the levels of population-level spacer diversity in a pre-immunized 
host population [14], we predicted that increased bottlenecking of an initially susceptible host 
population, where CRISPR diversity evolves upon phage infection, could cause a breakdown 
in host diversity, removing the synergistic benefits of CRISPR, and hence cause an increase 
in phage persistence.  
Results 
To understand the effect of bottlenecking on host and phage population dynamics, we 
infected either the WT PA14 strain or PA14 csy3::lacZ strain, which carries an inactive 
CRISPR-Cas system (hereafter referred to as ΔCRISPR) with phage DMS3vir in liquid 
media and transferred daily into fresh medium while manipulating the bottleneck size by 
varying the dilution factor at each daily transfer from 10
–2
 (weakest bottleneck) to 10
–9
 
(strongest bottleneck). Ancestral WT PA14 carries no spacers targeting DMS3vir, so is 
sensitive to infection.  
Surprisingly, phage went (close to) extinct in all treatments by 5 days post-infection (d.p.i.), 
irrespective of the bottleneck strength (Figure 1), and importantly CRISPR background had 
no significant effect on phage titres (F1,334 = 2.12, p = 0.15), although there appeared to be a 
transient effect at the 10
-4
 and 10
-5
 bottleneck treatments (see Discussion). Phage extinction 
risks were also almost identical between these host genetic backgrounds for all bottlenecks 
(Table S1). Although there was a significant effect of CRISPR background on host titres 
(F1,432 = 143.2, p < 0.0001), this was likely due to the transiently higher average host 
densities at 2 d.p.i. in all treatments (Figure 2) (see Discussion). Adjusted R
2
 comparisons of 
nested models showed that the effect of CRISPR background explained only 10% more 
variance than a model excluding the CRISPR background interaction. Otherwise, host 
dynamics within comparable treatments were similar in CRISPR and ΔCRISPR backgrounds. 
These data therefore suggest that CRISPR-Cas systems overall have a negligible and 
transient impact on the short-term phage population dynamics under the bottlenecking 
regimes that were explored here.  
 Although the presence or absence of a functional CRISPR-Cas system did not have a 
strong impact on the phage population dynamics, the bottlenecking regime itself did have a 
clear impact with stronger bottlenecks being associated with a more rapid decline in phage 
titers. This is supported by a control without phage, which shows that host densities remain 
relatively stable through all but the strongest bottleneck treatments (Figure S1). We also ruled 
out any abiotic effects of fresh media that may have disproportionately impacted phage 
survival ([37]; Figure S2). We hypothesized this might be caused by a dilution effect, i.e. a 
decrease in host densities resulting in reduced parasite spread [16,17]. To explicitly test this, 
we first selected two bottleneck treatments (10
–4
 and 10
–6
) that showed clear differences in 
phage titers over time. We then set up an experiment as described above with WT PA14 and 
DMS3vir, and at 1 d.p.i. diluted the culture 100-fold and transferred daily 0.6µl into either 
6ml or 600ml of fresh media, generating either 10
–4
 or 10
–6
 dilutions while maintaining the 
same degree of bottlenecking on the population. We found that the small and large dilutions 
of bacterial populations led to a qualitatively similar phage population dynamics as those 
associated with the 10
–4
 and 10
–6
 bottleneck treatments, respectively (Figure 3). Phage 
persisted in most small dilution replicates until 4 d.p.i, while in the large dilution it was 
driven extinct in all but one replicate by 3 d.p.i. Host persisted for the duration of the 
experiment in the small dilution treatment, but were undetectable in 5 out of 6 large dilution 
replicates by 3 d.p.i., and in 3 out of 6 replicates of the 10
–6
 bottleneck treatment, also by 3 
d.p.i. These data therefore support the conclusion that phage population dynamics observed 
in the bottleneck experiment were driven primarily by dilution of the phage. Interestingly, 
phage titre did not covary significantly with host density in the bottleneck (F68,247 = 1.06, p = 
0.37) or dilution experiment (F13,98 = 0.43, p = 0.96), which suggests that phage dynamics are 
not correlated with those of the host, and consequently are likely more negatively affected by 
bottlenecking than the host.  
 Given the observed effect of bottlenecking on the phage population dynamics, we 
investigated whether this could have knock-on effects for the evolution of host resistance to 
the phage, and the mechanistic basis for resistance evolution. For consistency with previous 
studies [9], we examined the phage resistance phenotypes at 3 d.p.i. Hosts with CRISPR 
immunity were most frequent in the 10
-2
 – 10-5 bottleneck treatments, which all contained 
detectable levels of phage at 3 d.p.i. However, bottlenecks of 10
–6
 – 10-9 contained mostly 
sensitive hosts (Figure 4A & Table S2), which we hypothesized was due to the lower levels 
of phage in those treatments. A qualitatively similar pattern in the evolution of immune 
phenotypes was observed in the dilution experiment (Figure S3 & Table S4). This shift from 
CRISPR immunity to sensitive bacteria was therefore potentially due to relaxed selection for 
host immunity as a result of phage dilution. To test this idea, performed a similar experiment 
where we bottlenecked cultures (both WT and the ΔCRISPR strain) in the same way as 
described above but with a fixed dilution of 10
-2
 for the phage. This experimental design 
therefore results in bottlenecking and dilution of the hosts while maintaining a similar phage 
pressure across the bottleneck treatments. Under these conditions, CRISPR immunity was 
maintained across the range of treatments and there was no invasion of sensitives (Figure 4B 
& Table S3). There was again no significant covariance between phage titre and host density 
in this control (F65,250 = 1.23, p = 0.14), so that even when phage levels were maintained 
through each bottleneck, host and phage dynamics were not correlated. Although sensitive 
invasion did not occur in a ΔCRISPR background when phage were supplemented, 
intriguingly there was also no sensitive invasion when both host and phage were bottlenecked 
(Figure S4).  
Discussion 
Population bottlenecks often cause strong reductions in genetic diversity [19]. In the context 
of host-parasite interactions, bottlenecks can in theory benefit either the host [33, 34] or the 
pathogen [17, 26, 27] by affecting host-pathogen coevolution. Bottlenecks may also benefit 
the host through a dilution effect [28, 29].While there is limited empirical support for a 
dilution effect in a bacteria-phage system [30], and that bottlenecking benefits bacterial hosts 
[35], we predicted that bottlenecking of bacterial populations that evolve CRISPR immunity 
against phages would benefit the pathogen [36], because CRISPR spacer diversity can rapidly 
drive phages extinct [14].  
In contrast to our predictions, bottlenecking did not provide a clear advantage to the phage. 
Instead, phage were always driven extinct by 5 d.p.i. irrespective of the degree of population 
bottlenecking. Surprisingly, this effect was not CRISPR-specific but seemed to be driven 
instead by bottlenecking per se, as suggested by similar phage dynamics in the context of a 
CRISPR-knockout strain. Exploring the potential role of a dilution effect through 
bottlenecking, we found that dilution alone is sufficient to drive phage extinct in a CRISPR 
background. In support of this, phage density was uncoupled from host density in all 
experiments and phage extinction was more rapid after 10
–6
 bottlenecks in cultures with 
surviving host. Both findings are consistent with dilution disproportionately affecting phage. 
This biased effect on phage may be related to the different resource requirements of bacteria 
and phage. After passing through even very small bottlenecks, bacterial cells can still 
replicate if environmental resources are available. By contrast, phage cannot replicate 
independent of hosts - they require a sufficient number and density of host cells to recover 
after a bottleneck has been applied. Such an imbalance in resource dependence between 
bacteria and phage, coupled with a reduction in numbers of individual hosts, might explain 
why phage were more susceptible to dilution. While dilution of hosts can suppress phage 
epidemics, this will quantitatively depend on phage life history traits, such as adsorption 
rates, latent period and burst size of the phages. It would be interesting therefore to further 
explore how these factors affect phage persistence and evolution in the context of host 
dilution.  
From the perspective of the bacterial host, a dilution effect relaxed selection for CRISPR 
immunity and allowed sensitive hosts to invade, particularly in the stronger bottleneck 
treatments of 10
–6
 and above. However, we did not see a similar invasion of sensitives in the 
ΔCRISPR background. It is unclear why sensitives did not invade, but we speculate that it 
might be attributable to either hosts with CRISPR immunity losing their resistance [38, 39], 
or the CRISPR fraction of the host population ‘protecting’ sensitive hosts at the start of an 
infection [40], allowing them to invade after already dilute phage have been cleared. When 
phage were supplemented, sensitives could not invade and CRISPR immunity was most 
relatively frequent.  
Finally, although our results are generally consistent with a dilution being the most important 
determinant of the phage population dynamics, we did detect some transient effects which are 
likely driven by CRISPR immunity. First, transiently higher average host densities at 2 d.p.i. 
in all treatments (Figure 2) may at least be partially due to a difference in how quickly hosts 
with CRISPR immunity versus surface modification (SM) invade the culture. Second, in the 
experiment where only the host was bottlenecked (resulting in high levels of CRISPR 
resistance evolution at all treatments), phage titres were statistically similar across bottleneck 
treatments at all timepoints for the WT bacteria with functional CRISPR-Cas (Figure S5A), 
but not for the ΔCRISPR bacteria (Figure S5B). Third, in the experiment where the whole 
culture was bottlenecked, phage titres in the 10
–4
 and 10
–5
 treatments were consistently 
significantly higher at most timepoints compared to the ΔCRISPR background (Figure 1), 
supported by a one-way ANOVA of the effect of host background on phage titre across the 
whole 6-point time series (F1,36 = 8.92, p < 0.01). These phage titres were maintained despite 
10,000- and 100,000-fold reductions of phage immediately after the bottlenecking had been 
applied, suggesting that phage were still able to successfully amplify on sensitive hosts. High 
phage titres in these treatments occurred in the context of high relative frequency of CRISPR 
immunity in the host, raising the possibility of an interaction between CRISPR, host density, 
and bottlenecking of a certain degree that appears to temporarily favour phage. This suggests 
that within a certain range of bottleneck treatments CRISPR defenses may become less 
effective in driving phages extinct, either because of population dynamics or evolutionary 
effects, or both. 
 Altogether, this study provides further insight into how bottlenecking influences 
bacteria-phage dynamics and the evolution of host resistance. Bottlenecking does impact the 
ability of phage to coexist with the host, but this is generally independent of whether or not 
the host has a functional CRISPR-Cas immune system. Instead, our findings support the role 
of a dilution effect caused by bottlenecking that disproportionately affects phage titre and 
survival. However, we also find some CRISPR-specific effects under certain conditions that 
may be related to a complex interaction between host immune systems and host-pathogen 
dynamics.  
 
Materials & Methods 
Bacterial strains & phage 
The bacterial strains and phages used in this study have all been described previously. 
Evolution experiments were carried out using Pseudomonas aeruginosa UCBPP-PA14 (WT) 
and phage DMS3vir [41]. We used P. aeuruginosa UCBPP-PA14 csy3::lacZ [42] in 
CRISPR-negative control experiments and streak assays, and DMS3vir-AcrF1 [14] in streak 
assays.  
Bottleneck experiments 
All experiments were established in glass vials by inoculating 6ml of M9 minimal media 
(supplemented with 0.2% glucose) with ~1x10
6
 c.f.u. (colony-forming units) from an 
overnight culture of WT P. aeruginosa PA14. Approximately 1x10
4
 p.f.u. (plaque-forming 
units) of DMS3vir was added to each glass vial. A phage-negative control was established 
similarly but without the addition of phage. A CRISPR-negative control was also established 
by inoculating 6ml of M9 minimal media with ~1x10
6
 c.f.u. of P. aeruginosa PA14 
csy3::lacZ and ~1x10
4
 of DMS3vir. At this point (0 d.p.i.), 180μl of culture was taken from 
each vial and phage was extracted using chloroform. To determine phage titres, extracted 
phage was then serially diluted eight times in 96-well plates, and 5μl of each phage dilution 
was spotted on a top lawn of P. aeruginosa PA14 csy3::lacZ. The detection limit of phage 
spot assays is 10
2
 p.f.u. ml
–1
. Samples of culture were serially diluted in M9 minimal media, 
plated on LB agar and incubated overnight at 37˚C. C.f.u.s were counted to determine host 
densities. The vials were then incubated at 37˚C while shaking at 180rpm.  
After 24hrs of growth (1 d.p.i.) the phage and host sampling protocol, described above, was 
repeated. To generate bottleneck treatments, samples of culture were then serially diluted in 
M9 minimal media from 10
–1
, 10
–2, …10–7. 60μl from undiluted culture and each dilution 
were then used to inoculate 6ml of fresh M9 minimal media. This method of dilution and 
transfer gives eight bottleneck treatments of 10
–2
, 10
–3, …10–9. To ensure only the host was 
bottlenecked in the phage-supplemented control, we added 60μl of chloroform-extracted 
phage from the corresponding replicate into each inoculated microcosm. Each bottleneck was 
performed in six independent replicates (N = 6). Host and phage sampling, as well as the 
bottlenecking procedure in each treatment, was repeated 24hrs after growth in fresh medium 
until 5 d.p.i. Samples of the culture were taken prior to bottlenecking. 
Dilution experiment 
We explicitly tested the effect of culture dilution on population dynamics and immunity 
evolution. Twelve glass vials with 6ml M9 minimal media were established with WT 
P. aeruginosa PA14 and DMS3vir as described above, and the host and phage were assayed. 
We then established two dilution treatments that corresponded to the 10
–4
 and 10
–6
 bottleneck 
treatments, treatments which showed clear differences in phage titers over time. At 1 d.p.i., 
all twelve cultures were serially diluted. Six vials (N = 6) of 6ml M9 minimal media were 
inoculated with 60μl of the 10–2 dilution (0.0006ml/6ml = 1x10–4). Six bottles (N = 6) of 
600ml M9 minimal media were also inoculated with 60μl of the 10–2 dilution 
(0.0006ml/600ml = 1x10
–6
). Sampling (as described above) and dilution were repeated 24hrs 
after growth in fresh medium until 5 d.p.i. Samples of the culture were taken prior to dilution. 
Determining host immune phenotype 
Bacterial immunity against ancestral phage was determined at 3 d.p.i, using two independent 
assays as described in Westra et al [9]. First, bacteria were plated on LB-agar, and 24 
randomly-selected individual clones per replicate were streaked through either DMS3vir or 
DMS3vir-AcrIF1, which encodes an anti-CRISPR gene. Clones sensitive to both phage 
genotypes were scored as ‘sensitive’; those resistant to the DMS3vir but sensitive to 
DMS3vir-AcrIF1 were scored as ‘CRISPR resistant’; and those resistant to both were scored 
as ‘surface mutant (SM)’. Second, each clone was also grown for 24hrs in M9 media in the 
presence or absence of DMS3vir, and the OD600 was measured. Cultures that had a reduced 
growth rate were scored as sensitive.  
Statistical analysis 
All statistical analyses were conducted in R [43]. We took a nested Generalized Linear Model 
(GLM) approach, and model selection was performed using Aikaike’s Information Criteria 
(AIC) [44, 45]. Models of phage titre and host densities used log-transformed residuals to fit 
the assumption of normality, and coefficients were back-transformed prior to presentation. 
Models of phenotype relative frequency used a binomial family with a logit link, and logit 
coefficients were back-transformed to probability values. We used a Cox proportional 
hazards model to assess the effect of bottleneck size on phage survivorship over the course of 
an experiment, with hazard ratio coefficients expressing the relative risk of phage extinction 
over time. ‘Bottleneck’ was treated as a discrete variable in all models. The package ggplot2 
was used to generate graphics [46].  
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Figure Captions 
 
 
Figure 1 Phage population dynamics when both host and phage are bottlenecked. Mean 
plaque-forming units (p.f.u.) ml
–1
 for the WT host (i.e. encoding a functional CRISPR-Cas 
immune system) and the ΔCRISPR strain are shown for different bottleneck treatments 
(ranging from 10
-2
-10
-9
 dilutions at each transfer, as indicated above each panel). The 
detection limit is 200 p.f.u. ml
-1
. Error bars correspond to 95% confidence intervals (CIs). N 
= 6 for all treatments.  
 
 
 Figure 2 Host population dynamics when both host and phage are bottlenecked. Mean 
colony-forming units (c.f.u.) ml
–1
 for the WT host (i.e. encoding a functional CRISPR-Cas 
immune system) and the ΔCRISPR strain are shown for different bottleneck treatments 
(ranging from 10
-2
-10
-9
 dilutions at each transfer, as indicated above each panel). The 
detection limit is 200 c.f.u. ml
-1
. Error bars correspond to 95% confidence intervals (CIs). N 
= 6 for all treatments.  
 
 
 Figure 3 Phage and host dynamics when both WT host and phage are diluted or 
bottlenecked. A 10
-4
 or 10
-6
 bottleneck corresponds to either 0.6µl or 0.006µl culture, 
respectively, in 6ml of fresh media at each transfer. A 10
–4
 dilution corresponds to 0.6µl 
culture in 6 ml at each transfer, and a 10
-6
 dilution corresponds to 0.6µl culture in 600 ml at 
each transfer (see Materials & Methods). Mean plaque-forming units (p.f.u.) ml
–1
 and colony-
forming units (c.f.u.) for the dilution and comparable bottleneck treatments are shown. The 
detection limit is 200 p.f.u. or c.f.u. ml
-1
. Error bars correspond to 95% confidence intervals 
(CIs). N = 6 for all treatments.  
 
 
 Figure 4 Evolution of host resistance of the WT strain. Relative frequencies of bacterial 
clones with CRISPR immunity, surface mutation (SM) resistance, or sensitive phenotypes, at 
3 days post-infection when A) both host and phage were bottlenecked by dilution into fresh 
medium as indicated on the x-axis s and B) host was bottlenecked by dilution into fresh 
medium as indicated on the x-axis and phage was bottlenecked at a fixed 10
-2
 dilution at each 
transfer. Error bars correspond to 95% confidence intervals (CIs) of the mean. N=72 for the 
10
-6
 treatment in panel A, and N=48 for the 10
-8
 treatment in panel B. No bacterial cells were 
recovered from any replicate in the 10
-9
 treatment in panel B. N =144  for all other treatments. 
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Comparison Hazard Ratio Standard Error z  p  
ΔCRISPR CRISPR 
    
      
10
–2 
 10
–2 
 0.35  2.31  -1.26 1.00 
10
–3
  10
–3
  0.24  2.12  -1.93 0.84 
10
–4 
 10
–4 
 0.19  2.31  -1.98 0.81 
10
–5
  10
–4
  1.46  2.03  0.53 1.00 
10
–6
  10
–6
  0.10  2.31  -2.80 0.24 
10
–7
  10
–7
  1.31  2.03  0.39 1.00 
10
–8
  10
–8
  4.36  2.11  1.97 0.82 
10
–9
  10
–9
  2.68  2.08  1.34 0.99 
 
Table S1 Tukey’s significant difference tests of phage extinction hazard ratios between 
bottleneck treatments in ΔCRISPR and CRISPR background 
 
 
 
 
 
CRISPR Sensitive SM 
Bottleneck Mean 95% CIs  Mean 95% CIs  Mean 95% CIs  
       
10
 –2
  0.92  0.87–0.96 0.04  0.02–0.08 0.03  0.01–0.07 
10
–3 
 0.88  0.82–0.93 0.03  0.01–0.07 0.08  0.05–0.14 
10
–4
  0.76  0.69–0.83 0.05  0.02–0.09 0.19  0.13–0.26 
10
–5
  0.82  0.75–0.88 0.08  0.05–0.14 0.10  0.06–0.15 
10
–6
  0.38  0.27–0.49 0.61  0.50–0.72 0.01  0.00–0.06 
10
–7
  0.24  0.17–0.31 0.73  0.65–0.80 0.03  0.01–0.07 
10
–8
  0.13  0.08–0.19 0.88  0.81–0.92 0.00  0.00–0.00 
10
–9
  0.13  0.08–0.20 0.87  0.80–0.92 0.00  0.00–0.00 
       
Table S2 Mean relative frequency and 95% CIs of CRISPR, sensitive and SM immune 
phenotypes in the bacterial culture at 3 d.p.i. when both the host and phage are bottlenecked 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
CRISPR Sensitive SM 
Bottleneck Mean 95% CIs  Mean 95% CIs  Mean 95% CIs  
       
10
 –2
  0.85  0.79–0.91 0.03  0.01–0.07 0.11  0.07–0.17 
10
–3 
 0.81  0.74–0.86 0.05  0.02–0.09 0.15  0.09–0.20 
10
–4
  0.75  0.68–0.82 0.08  0.04–0.13 0.17  0.12–0.24 
10
–5
  0.78  0.71–0.84 0.08  0.05–0.14 0.14  0.09–0.20 
10
–6
  0.74  0.66–0.80 0.13  0.08–0.18 0.13  0.09–0.18 
10
–7
  0.60  0.52–0.68 0.24  0.18–0.32 0.16  0.11–0.20 
10
–8
  1.00  1.00–1.00 0.00  0.00–0.00 0.00  0.00–0.00 
10
–9
  NA  NA  NA  NA  NA  NA  
       
Table S3 Mean relative frequency and 95% CIs of CRISPR, sensitive and SM immune 
phenotypes in the bacterial culture at 3 d.p.i. when host was bottlenecked and phage was 
supplemented at each transfer 
 
 
 
 
 
 
 
CRISPR Sensitive SM 
Bottleneck  Mean 95% CIs  Mean 95% CIs  Mean 95% CIs  
       
10
–4
 
bottleneck 0.76  0.69–0.82  0.05  0.00–0.09 0.19  0.13–0.26 
Small 
dilution  0.56  0.44–0.67  0.39  0.28–0.50 0.06  0.02–0.12 
10
–6
 
bottleneck 0.37  0.27–0.49  0.61  0.49–0.72 0.01  0.00–0.06 
Large 
dilution  0.08  0.01–0.0.32 0.92  0.68–0.99 0.00  0.00–0.00 
       
 
      
Table S4 Mean relative frequency and 95% CIs of CRISPR, sensitive and SM immune 
phenotypes in the bacterial culture at 3 d.p.i. when host was either bottlenecked or 
comparably diluted 
 
 
  
 
Figure S1 Host population dynamics when WT P. aeruginosa PA14 host is bottlenecked in 
the absence of phage (phage-negative control). Mean colony-forming units (c.f.u.) ml
–
are 
shown for different bottleneck treatments (ranging from 10
-2
-10
-9
 dilutions at each transfer, as 
indicated above each panel). The detection limit is 200 c.f.u. ml
-1
. Error bars correspond to 
95% confidence intervals (CIs). N = 6 for all treatments.  
  
  
Figure S2 Boxplots of DMS3vir titre (plaque-forming units (pfu) ml
-1
) after overnight 
incubation in used and new media (N=6). We inoculated 6ml of M9 minimal media 
(supplemented with 0.2% glucose) with WT P. aeruginosa PA14 at 1:10
2
, 1:10
3,…1:109 from 
an overnight culture (exactly like the bottleneck experiments described in the manuscript). 
We then incubated these overnight at 37˚C and 180rpm. The next day, we plated out dilutions 
of the culture to measure host density (purple). We then removed bacterial cells to generate 
“used media” for each dilution treatment. This was done by centrifuging 5 ml of culture at 
3500rpm for 25 mins, followed by filtering through 0.45µm filters into clean glass vials. 10
8 
pfu ml
-1
 DMS3vir was then added to each preparation, and also to fresh (new) media. To 
measure phage titre, samples of the preparations then underwent a chloroform extraction 
followed by spot assays on a top lawn of P. aeruginosa PA14 csy3::lacZ. The preparations 
were then incubated overnight at 37˚ and 180rpm. The next day, phage titres were again 
measured using chloroform extraction followed by spot assays.  
  
  
Figure S3 Mean relative frequencies of bacterial clones with CRISPR immunity, surface 
mutation (SM) resistance, or sensitive phenotypes, at 3 days post-infection. A 10
-4
 or 10
-6
 
bottleneck corresponds to either 0.6µl or 0.006µl culture, respectively, in 6ml of fresh media 
at each transfer. A 10
–4
 dilution corresponds to 0.6µl culture in 6 ml of fresh media at each 
transfer, and a 10
-6
 dilution corresponds to 0.6µl culture in 600ml of fresh media at each 
transfer (see Materials & Methods). Error bars correspond to 95% confidence intervals (CIs). 
N=6 for all treatments 
  
 
Figure S4 Mean relative frequencies of bacterial clones with CRISPR immunity, surface 
mutation (SM) resistance, or sensitive phenotypes, at 3 days post-infection in a ∆CRISPR 
background A) When both host and phage were bottlenecked and B) when host was 
bottlenecked and phage supplemented at each transfer. Error bars correspond to 95% 
confidence intervals (CIs) N=6 for all treatments.  
 
  
 Figure S5 Phage dynamics when both only the host is bottlenecked in A) CRISPR 
background and B) ∆CRISPR control. Mean plaque-forming units (p.f.u.) ml-1 are shown. 
Values of 10
0
 represent phage titres of zero, rather than one. Error bars correspond to 95% 
confidence intervals (CIs). N=6 for all treatments. 
 
 
